CEFOTAXIME (CEFOTAXIME SODIUM) — all Canadian products
15 DINs
0 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is CEFOTAXIME (CEFOTAXIME SODIUM), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02097184 | CEFOTAXIME FOR INJECTION USP | NOVOPHARM LIMITED | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME (CEFOTAXIME SODIUM) 500 MG | Cancelled Pre Market | |
| 02097206 | CEFOTAXIME FOR INJECTION USP | NOVOPHARM LIMITED | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME (CEFOTAXIME SODIUM) 2 G | Cancelled Pre Market | |
| 02097192 | CEFOTAXIME FOR INJECTION USP | NOVOPHARM LIMITED | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME (CEFOTAXIME SODIUM) 1 G | Cancelled Pre Market | |
| 02261499 | CEFOTAXIME SODIUM FOR INJECTION, BP | HOSPIRA HEALTHCARE ULC | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME (CEFOTAXIME SODIUM) 250 MG | Cancelled Pre Market | |
| 02261502 | CEFOTAXIME SODIUM FOR INJECTION, BP | HOSPIRA HEALTHCARE ULC | Powder For Solution | Intravenous; Intramuscular | CEFOTAXIME (CEFOTAXIME SODIUM) 500 MG | Cancelled Post Market | |
| 02261529 | CEFOTAXIME SODIUM FOR INJECTION, BP | HOSPIRA HEALTHCARE ULC | Powder For Solution | Intravenous; Intramuscular | CEFOTAXIME (CEFOTAXIME SODIUM) 2.0 G | Cancelled Post Market | |
| 02261510 | CEFOTAXIME SODIUM FOR INJECTION, BP | HOSPIRA HEALTHCARE ULC | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME (CEFOTAXIME SODIUM) 1.0 G | Cancelled Post Market | |
| 00546208 | CLAFORAN 0.5GM/VIAL | ROUSSEL CANADA INC. | Powder For Solution | Intravenous; Intramuscular | CEFOTAXIME (CEFOTAXIME SODIUM) 500 MG | Cancelled Post Market | |
| 00546216 | CLAFORAN 1GM/VIAL | ROUSSEL CANADA INC. | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME (CEFOTAXIME SODIUM) 1 G | Cancelled Post Market | |
| 00546224 | CLAFORAN 2GM/VIAL | ROUSSEL CANADA INC. | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME (CEFOTAXIME SODIUM) 2 G | Cancelled Post Market | |
| 01989758 | CLAFORAN ADD-VANTAGE VIALS 1GM/VIAL | HOECHST ROUSSEL CANADA INC. | Powder For Solution | Intravenous | CEFOTAXIME (CEFOTAXIME SODIUM) 1 G | Cancelled Post Market | |
| 00839248 | CLAFORAN INJ 1GM/ADD-VANTAGE VIAL | ROUSSEL CANADA INC. | Powder For Solution | Intravenous | CEFOTAXIME (CEFOTAXIME SODIUM) 1 G | Cancelled Post Market | |
| 01989812 | CLAFORAN PWS INJ 1.0GM/VIAL | HOECHST ROUSSEL CANADA INC. | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME (CEFOTAXIME SODIUM) 1 G | Cancelled Post Market | |
| 01989804 | CLAFORAN PWS INJ 2.0GM/VIAL | HOECHST ROUSSEL CANADA INC. | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME (CEFOTAXIME SODIUM) 2 G | Cancelled Post Market | |
| 01989766 | CLAFORAN PWS INJ 500MG/VIAL | HOECHST ROUSSEL CANADA INC. | Powder For Solution | Intramuscular; Intravenous | CEFOTAXIME (CEFOTAXIME SODIUM) 500 MG | Cancelled Post Market |
Browse other molecules: